NEW YORK--(BUSINESS WIRE)--American Oriental Bioengineering Inc. (AMEX: AOB)
Third Quarter 2006 Highlights:
Organic Revenue Growth of 63% during the Quarter
Consolidated Gross Margins improve 3.5% versus last year to 66.9%
Management Expects Fourth Quarter Revenue to be in the range of $37 million to $39 million and at least $0.15 in EPS
